dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Poveda, Andres |
dc.contributor.author | Lheureux, S. |
dc.contributor.author | Cibula, David |
dc.contributor.author | Weberpals, J. |
dc.contributor.author | Oaknin Benzaquen, Ana Mazaltob |
dc.contributor.author | Colombo, Nicoletta |
dc.contributor.author | Lindemann, Kristina |
dc.date.accessioned | 2022-09-05T11:59:18Z |
dc.date.available | 2022-09-05T11:59:18Z |
dc.date.issued | 2022-03 |
dc.identifier.citation | Poveda A, Lheureux S, Colombo N, Cibula D, Lindemann K, Weberpals J, et al. Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis. Gynecol Oncol. 2022 Mar;164(3):498–504. |
dc.identifier.issn | 0090-8258 |
dc.identifier.uri | https://hdl.handle.net/11351/8029 |
dc.description | Mantenimiento; Olaparib; Cáncer de ovarios |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Gynecologic Oncology;164(3) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Platí |
dc.subject | Ovaris - Càncer - Tractament |
dc.subject.mesh | Ovarian Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Platinum |
dc.title | Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.ygyno.2021.12.025 |
dc.subject.decs | neoplasias ováricas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | platino (metal) |
dc.relation.publishversion | https://doi.org/10.1016/j.ygyno.2021.12.025 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Poveda A] Initia Oncology, Valencia, Spain. [Lheureux S] Princess Margaret Hospital, Department of Medical Oncology, Toronto, ON, Canada. [Colombo N] University of Milan-Bicocca and European Institute of Oncology IRCCS, Milan, Italy. [Cibula D] General University Hospital in Prague, First Faculty of Medicine, Charles University, Prague, Czech Republic. [Lindemann K] Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. [Weberpals J] Ottawa Hospital Research Institute, Ottawa, ON, Canada. [Oaknin A] Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 35063276 |
dc.identifier.wos | 000809757900006 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |